OKG Capital
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
OXcan
9 Jan 2025
OXcan raises £9m Series A led by We Venture Capital and Cross-Border Impact Ventures to revolutionise early lung cancer detection
OXcan develops blood-based liquid biopsy tests using proteomics and AI to detect lung cancer at earlier stages, enabling minimally invasive screening designed to improve outcomes and reduce pressure on healthcare systems.
52North
6 Dec 2024
Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal
52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.
More venture news
- 21 Apr 2026
Cerca MagneticsCerca Magnetics raises £3.8m Series A led by Guinness Ventures for wearable quantum brain scanner
Series AHealth - 15 Apr 2026
GizmoGizmo raises £16m Series A led by Shine Capital to help students study with interactive AI platform
Series AEducation - 15 Apr 2026
TraqCheckTraqCheck raises £6m Series A led by IvyCap Ventures for HR recruitment and screening software
Series AEnterprise
